These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2929438)

  • 1. Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing.
    Della Bella P; Marenzi G; Tondo C; Doni F; Lauri G; Grazi S; Guazzi MD
    Am J Cardiol; 1989 Apr; 63(12):812-6. PubMed ID: 2929438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiarrhythmic drugs on canine atrial flutter due to reentry: role of prolongation of refractory period and depression of conduction to excitable gap.
    Inoue H; Yamashita T; Nozaki A; Sugimoto T
    J Am Coll Cardiol; 1991 Oct; 18(4):1098-104. PubMed ID: 1910060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing.
    Della Bella P; Tondo C; Marenzi G; Cipolla CM; Doni F; Grazi S; Rimondini A; Salvioni A; Guazzi MD
    Am J Cardiol; 1988 May; 61(13):1046-9. PubMed ID: 3284318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of disopyramide in the treatment of atrial flutter with overdrive pacing].
    Della Bella P; Marenzi G; Doni F; Tondo C; Cipolla C; Grazi S; Rimondini A; Salvioni A; Guazzi MD
    Cardiologia; 1989 Mar; 34(3):247-52. PubMed ID: 2743366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
    Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of excitable gap and pattern of resetting in atrial flutter for determining reentry circuit location.
    Della Bella P; Marenzi G; Tondo C; Cardinale D; Giraldi F; Lauri G; Guazzi M
    Am J Cardiol; 1991 Aug; 68(5):492-7. PubMed ID: 1872277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.
    Camm J; Ward D; Spurrell R
    Br Heart J; 1980 Sep; 44(3):240-7. PubMed ID: 7426181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone.
    Doni F; Della Bella P; Kheir A; Manfredi M; Piemonti C; Staffiere E; Rimondini A; Fiorentini C
    Am J Cardiol; 1995 Dec; 76(17):1243-6. PubMed ID: 7503004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of intravenous ibutilide versus procainamide for enhancing termination of atrial flutter by atrial overdrive pacing.
    Stambler BS; Wood MA; Ellenbogen KA
    Am J Cardiol; 1996 May; 77(11):960-6. PubMed ID: 8644646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of class IA antiarrhythmic drug on the common type of atrial flutter in combination with pacing therapy.
    Fujimoto T; Inoue T; Ogawa H; Miwa S; Ohnishi Y; Yoneda N; Kaneda S; Itoh S; Fukuzaki H
    Jpn Circ J; 1989 Mar; 53(3):237-44. PubMed ID: 2746840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of procainamide on refractoriness, conduction, and excitable gap in canine atrial reentrant tachycardia.
    Kus T; Derakhchan K; Bouchard C; Pagé P
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1707-13. PubMed ID: 1721162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the excitable gap in a functionally determined reentrant circuit. Studies in the sterile pericarditis model of atrial flutter.
    Niwano S; Ortiz J; Abe H; Gonzalez X; Rudy Y; Waldo AL
    Circulation; 1994 Oct; 90(4):1997-2014. PubMed ID: 7522990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter.
    Frame LH; Page RL; Hoffman BF
    Circ Res; 1986 Apr; 58(4):495-511. PubMed ID: 3698216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic alterations in human type I atrial flutter cycle length and monophasic action potential duration. Evidence of a fully excitable gap in the reentrant circuit.
    Stambler BS; Wood MA; Ellenbogen KA
    J Am Coll Cardiol; 1996 Feb; 27(2):453-61. PubMed ID: 8557920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic determinants of recurrent atrial flutter after successful termination by overdrive pacing.
    Gössinger HD; Siostrzonek P; Jung M; Wagner L; Mösslacher H
    Am J Cardiol; 1990 Feb; 65(7):463-6. PubMed ID: 2305685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of procainamide on the excitable gap composition in a canine model of atrial flutter.
    Jalil E; Laflamme M; Kus T
    Can J Physiol Pharmacol; 1997 Jan; 75(1):1-8. PubMed ID: 9101058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electropharmacologic effects of class I and class III antiarrhythmia drugs on typical atrial flutter: insights into the mechanism of termination.
    Tai CT; Chen SA; Feng AN; Yu WC; Chen YJ; Chang MS
    Circulation; 1998 May; 97(19):1935-45. PubMed ID: 9609087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Facilitating effect of propafenone pretreatment in the interruption of atrial flutter by transesophageal pacing].
    Doni F; Kheir A; Manfredi M; Piemonti C; Staffiere E; Todd S; Rimondini A
    Cardiologia; 1996 Feb; 41(2):135-40. PubMed ID: 8674092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transverse conduction capabilities of the crista terminalis in patients with atrial flutter and atrial fibrillation.
    Schumacher B; Jung W; Schmidt H; Fischenbeck C; Lewalter T; Hagendorff A; Omran H; Wolpert C; Lüderitz B
    J Am Coll Cardiol; 1999 Aug; 34(2):363-73. PubMed ID: 10440147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.